TAVR Researchers Look To Lower-Risk Patients, Less Data Demands

TAVR Researchers Look To Lower-Risk Patients, Less Data Demands-thegraysheet: Edwards Lifesciences' Sapien 3 valve looked good at the annual American College of Cardiology conference, including in intermediate-risk patients. Could it mean less follow-up demands for future approvals?